Gigaxonin is a key E3 ubiquitin ligase adapter protein essential for neuronal survival and function. Mutations in the GAN gene cause Giant Axonal Neuropathy (GAN), a severe autosomal recessive neurodegenerative disorder characterized by progressive motor and sensory neuropathy, along with central nervous system involvement.
Gigaxonin is a key E3 ubiquitin ligase adapter protein essential for neuronal survival and function. Mutations in the GAN gene cause Giant Axonal Neuropathy (GAN), a severe autosomal recessive neurodegenerative disorder characterized by progressive motor and sensory neuropathy, along with central nervous system involvement.
Overview
Gigaxonin (GAN) is a 59 kDa protein encoded by the GAN gene located on chromosome 16q24.1 [@bomont2000]. It belongs to the BAG family of co-chaperones, specifically the BAG3 subfamily, which play critical roles in protein quality control and cytoskeletal maintenance [@carrell2005].
Structure
Gigaxonin contains multiple functional domains:
N-terminal BAG domain: Mediates interaction with Hsp70 family chaperones
BACK domain: Required for E3 ubiquitin ligase activity
RING finger domain: Catalytic domain for ubiquitin transfer
The protein forms a complex with the Cullin-3 (CUL3) ubiquitin ligase to ubiquitinate target proteins for degradation [@zhang2019].
Normal Function
In the healthy nervous system, gigaxonin plays essential roles in:
Protein Quality Control: Partners with Hsp70 to refold or degrade misfolded proteins
Cytoskeletal Maintenance: Regulates microtubule and intermediate filament organization
[Autophagy](/entities/autophagy): Facilitates clearance of damaged organelles and protein aggregates
Synaptic Function: Maintains synaptic vesicle dynamics and neuronal connectivity
Role in Disease
Giant Axonal Neuropathy (GAN)
GAN is a devastating childhood-onset neurodegenerative disorder caused by recessive loss-of-function mutations in the GAN gene [@johnson2010]. The disease is characterized by:
Severe Peripheral Neuropathy: Progressive loss of motor and sensory function
Central Nervous System Involvement: Developmental delay, seizures, and intellectual disability
Distinctive Axonal Morphology: Giant axonal swellings due to neurofilament accumulation
Early-onset: Symptoms typically appear in early childhood
Neurodegeneration Mechanisms
Impaired Protein Degradation: Loss of gigaxonin leads to accumulation of damaged proteins
[Bomont et al., Identification of the gene encoding gigaxonin, a protein related to the ubiquitin-proteasome system (2000) (2000)](https://pubmed.ncbi.nlm.nih.gov/11025706/)
[Zhang et al., The E3 ligase activity of gigaxonin is essential for its function in protein degradation (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/30661061/)
[Johnson et al., Giant axonal neuropathy: natural history and clinical features (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20442643/)
[Kwon et al., AAV9-mediated gene therapy for giant axonal neuropathy (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32855563/)